MedPath

Combinations of Pharmacologic Smoking Cessation Treatments

Phase 1
Completed
Conditions
Smoking
Registration Number
NCT00018187
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

The purpose of this study is to test the effectiveness of a combination of the drugs bupropion and mecamylamine along with a nicotine patch as a therapy for smoking cessation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

VA Greater Los Angeles Healthcare System

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath